Perioperative chemotherapy improved survival in resectable adenocarcinoma of the stomach or lower esophagus

Abbruzzese, James L.
January 2007
ACP Journal Club;Jan/Feb2007, Vol. 146 Issue 1, p2
Academic Journal
The article cites a study on the treatment of patients with resectable gastroesophageal adenocarcinoma, which was conducted by medical researcher D. Cunningham and colleagues. The study was concerned with the use of surgery plus perioperative chemotherapy, and surgery alone, for the treatment of patients with resectable gastroesophageal adenocarcinoma. The study concluded that surgery plus perioperative chemotherapy is more effective than surgery alone.


Related Articles

  • Phase I trial of pemetrexed plus oxaliplatin administered every other week in patients with metastatic cancer. Daniel Stover; A. Lockhart; Jordan Berlin; Emily Chan; Alan Sandler; Jeffery Sosman; Victoria Middlebrook; Steven Nicol; Mace Rothenberg // Investigational New Drugs;Aug2008, Vol. 26 Issue 4, p339 

    Summary   Purpose: To identify the maximum tolerated dose (MTD) and describe dose-limiting toxicities (DLT) of pemetrexed and oxaliplatin given on a once-every-2-week schedule in patients with metastatic cancer. Patients and methods: Twenty-five patients were enrolled. Due to toxicities...

  • Brain Metastases from Epithelial Ovarian Cancer: A Review of the Literature. Dimitrios Pectasides // Oncologist;Mar2006, Vol. 11 Issue 3, p252 

    BACKGROUND: Brain metastases from epithelial ovarian cancer (EOC) are rare. This report is based on a review of the literature. METHODS: and Results. This review summarizes the incidence, clinical features, pathophysiology, and diagnostic evaluation of EOC. The section on current treatment...

  • The Clinical Investigation of Pemetrexed Plus Carboplatin as an Active and Tolerable Treatment Plan in Chinese Elderly Patients with Advanced Lung Adenocarcinoma. Yu-Quan Wu; Jun Yang; Xi-Jian Zhou; Peng Li; Xiao-Qiang Fan; Guang-Zhou Lu; Yan-JuanPan; Xiang-Yong Li; Fu-Lin Yan // Journal of Cancer Therapy;Aug2011, Vol. 2 Issue 3, p311 

    The standard chemotherapy for Chinese elderly patients with non-small cell lung cancer (NSCLC) remains undefined. The study was to evaluate the therapeutic effects as well as side effects of pemetrexed plus carboplatin regimen as the first-line therapy for Chinese elderly patients with advanced...

  • Histology Matters: Individualizing Treatment in Non-Small Cell Lung Cancer. NEAL, JOEL W. // Oncologist;Jan2010, Vol. 15 Issue 1, p3 

    In this article, the author addresses specific treatment implications in non-small cell lung cancer (NSCLC) for each histological subtype. He stated that for patients having adenocarcinoma, first-line treatment consists of bevacizumab and four to six cycles of platinum containing chemotherapy...

  • D2 Lymph Node Dissection Improves Staging in Patients with Gastric Adenocarcinoma. PUTCHAKAYALA, KRISHNA; DIFRONZO, L. ANDREW // American Surgeon;Oct2011, Vol. 77 Issue 10, p1326 

    Debate continues over the recommended extent of routine lymphadenectomy for gastric cancer. Although evidence of improved locoregional control with extended dissection accumulates, understaging and stage migration continue to confound the issue. Our objective was to determine whether D2 lymph...

  • Fully Covered Alimaxx Esophageal Metal Stents in the Endoscopic Treatment of Benign Esophageal Diseases. Senousy, Bahaa; Gupte, Anand; Draganov, Peter; Forsmark, Chris; Wagh, Mihir // Digestive Diseases & Sciences;Dec2010, Vol. 55 Issue 12, p3399 

    Background: Expandable esophageal stents are widely used for the palliation of dysphagia in patients with esophageal cancer and are also beginning to be used in patients with benign esophageal diseases such as refractory strictures and fistulas. There is concern regarding the increased risk of...

  • A MULTIMODALITY APPROACH TO PERITONEAL CARCINOMATOSIS: DON'T FORGET THE SURGEON. Ruffin, W. Kirkland; Johnson, David; Cattau Jr., Edward L. // American Journal of Gastroenterology;Oct1995, Vol. 90 Issue 10, p1896 

    Expresses views on the study "Prognostic Features of 51 Colorectal and 130 Appendiceal Cancer Patients With Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy." Overview of the study; Findings about the natural history and metastatic pattern of tumors;...

  • More on Breast Cancer in the Elderly. Ershler, William B. // Clinical Oncology Alert;Oct2007, Vol. 23 Issue 10, p78 

    ONCOLOGISTS HAVE BECOME INCREASINGLY aware of geriatric issues relating to cancer management. These issues are particularly relevant to breast cancer because the majority of patients are over the age of 65 years and there are important and well recognized age-associated differences in tumor...

  • Predicting clinical outcome of 5-fluorouracil-based chemotherapy for colon cancer patients: is the CpG island methylator phenotype the 5-fluorouracilresponsive subgroup? Iacopetta, Barry; Kawakami, Kazuyuki; Watanabe, Toshiaki // International Journal of Clinical Oncology;Dec2008, Vol. 13 Issue 6, p498 

    The CpG island methylator phenotype (CIMP+) of colorectal cancer (CRC) occurs predominantly in the proximal colon and is characterized by frequent hypermethylation of gene promoter regions. In this review, we present evidence suggesting CIMP+ represents the subgroup of colon cancers that are...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics